May 29, 2020

2nd Edition (E-COVID)

E-Meeting on COVID-19: Coronavirus Pandemic

Join us from anywhere in the world, wherever you feel comfortable.
What you need : A laptop, desktop computer, tablet or mobile phone.
E-COVID

About the Conference

A novel strain of coronavirus (2019-nCoV) was detected in December 2019 and Coronavirus Disease 2019 (COVID-19) has quickly progressed to a global health emergency. The World Health Organization and the Centers for Disease Control and Prevention have declared COVID-19 as a public health crisis.

In these times of travel ban and social distancing, we hope that research and flow of knowledge does not come to a halt. In our endeavors to do so, United Scientific Group has decided to host Second Edition of online meeting on “COVID-19: Coronavirus Pandemic” on May 29, 2020 EDT Time Zone.

As a meeting organizer, we will make sure to discuss the relevant research information in diagnosis, treatment, prevention and further research in this disease and to support the virtual efforts of healthcare practitioners globally.

  • (1) limited travel grants
  • (2) lack of time to travel to distant conference locations;
  • (3) Insufficient accommodation and subsistence funds.
Submit Abstract

Previous Speakers

Edith P. Mitchell

Edith P. Mitchell

Thomas Jefferson University, Philadelphia, PA

Title: Corona Virus: Global Pandemic Causing World-Wide Shutdown


Biography : Mitchell joined the faculty at the University of Missouri as an assistant professor of medicine and was the recipient of their 1991 Distinguished Service Award. In 1993, she led a team of microbiologists to help combat a flood in Missouri and Mississippi. In 2001, she became the first African-American female in the Missouri Air National Guard to be promoted to Brigadier general. Upon retiring from the United States Air Force, she joined the faculty of medicine and medical oncology at Thomas Jefferson University and became the associate director of Diversity Programs for the Sidney Kimmel Comprehensive Cancer Center at Jefferson. She has also received the National Medical Association Council on Concerns of Women Physicians Pfizer Research Award for her "outstanding contributions to clinical or academic medicine. In August 2015, Mitchell was appointed president of the National Medical Association for a one-year term.

Steven LOH Cheng Toa

Steven LOH Cheng Toa

NTU Chinese Medicine Clinic, Singapore

Title: TCM's Intervention and Effects on COVID-19: Introducing the Few Most Commonly used Concoctions during Treatment


Biography : Steven Loh is a registered TCM physician/acupuncturist (Singapore), Registered doctor (Chinese Medicine) in China, Senior Physician at NTU Chinese Medicine Clinic, Nanyang Technological University, Singapore, adjunct doctor at XianCi Chinese Medicine Nephrology Hospital. Dr Loh obtained his Doctorate in Clinical Medicine from Nanjing University of Chinese Medicine. His clinical interest and experience include: Coronary Heart Diseases, Geriatrics, Stroke Recovery and Aftercare, Renal Disorder, Sports Injuries, Pain Management, Hyperhidrosis, Insomnia.

Jan Tesarik

Jan Tesarik

MARGen Clinic, Spain

Title: Melatonin to Reduce Death Toll Due to Covid-19: From Innate to Adaptive Immune Response


Biography : Dr. Jan Tesarik obtained his MD degree in 1979 and PhD in 1982. Between 1988 and 1996, he worked at the INSERM Unit 187 in Clamart, and then in the American Hospital of Paris. He is author of >400 scientific publications, including 307 highly influential publications listed in Semantic Scholar. At present he is Director of MARGen (Molecular Asssisted Reproduction and Genetics) Clinic in Granada (Spain) and coordinates different research projects carried out at the University of Granada.

P R Raghavan

P R Raghavan

Nanorx Inc, Chappaqua, NY

Title: Metadichol ® ; Natures Own Remedy to the Corona Virus


Biography : P R Raghavan is an experienced Chief Executive Officer with a demonstrated history of working in the pharmaceuticals industry. He is skilled in Nano technology, Patent Law, Biotechnology, Drug Development, Drug Discovery, and Licensing and International marketing. He is a strong entrepreneurship professional graduated with a Ph.D (Organic Chemistry) from Oregon State University, Corvallis, Oregon, USA.

Miku Sodhi

Miku Sodhi

Shasta Cascade Health Centers, Mount Shasta, CA

Title: Perspective On Recent Drug Use For COVID-19 and Impact of Health Disparities on Testing and Transmission


Biography : Dr. Miku Sodhi leads Shasta Cascade Health Centers in California as its Deputy CEO. He was trained as medical doctor in Mauritius and India. He is a seasoned health care executive with experience in clinical operations, health care organizational transformation, strategy, public health and medicine in the US. He holds a Medical degree from University of Mauritius. He also holds a Masters in Health Administration degree from California State University East-Bay. He was a Geiger-Gibson Fellow in Community Health Policy at George Washington University- Milken School of Public Health. Dr. Sodhi holds Executive Fellowship in Community Health leadership from University of Kansas Medical Center, a certificate in health care executive leadership from Harvard University T.H. Chan School of Public Health. He is a Board Certified health care executive and a Fellow of American College of Medical Practice Executives (ACMPE). He is certified as Patient Centered Medical Home content expert via National Committee for Quality Assurance (NCQA) and has transitioned health care systems to become accredited medical homes. He has lead health systems, hospitals, and Federally Qualified Health Centers (FQHC) in US in multiple executive leadership roles.

George Kroumpouzos

George Kroumpouzos

Brown University, Providence, RI

Title: Challenges of COVID-19 Pandemic for Dermatology


Biography : George Kroumpouzos, MD, PhD, FAAD is Clinical Associate Professor of Dermatology at Brown University and Professor of Dermatology, Collaborator, at Jundiaí Medical School, São Paulo, Brazil. He has served as Instructor of Dermatology at Harvard Medical School. Dr. Kroumpouzos has authored several articles on COVID-19, especially in regards to Dermatology. He has published more than 100 peer-reviewed articles and 27 book chapters. He is the Editor of 2 monographs and 3 books including the definitive Text Atlas of Obstetric Dermatology.

Felicia Andrei

Felicia Andrei

University of Medicine and Pharmacy Victor Babes, Romania

Title: An Important Helping Hand of Homeopathy


Biography : Felicia Andrei is a PhD in Medicine (Anathomy and Embriology) and a pharmacist specialized in Clinical Pharmacy and Homeopathy with two Masters degrees: one in Pharmacy -Formulation and evaluation of the dermatocosmetic product and the other in Polytechnic
Computer Automation - Information Systems in Health Care. Currently, she ia an Assistant Professor of the Faculty of Pharmacy in Timisoara with expertise in dermatopharmacy and cosmethology. She is an active member in the College of Pharmacists (Romania) and of the European Federation for Pharmaceutical Sciences as well as in the Union for Diplomate homeopathic physicians.

Daniela Bacherini

Daniela Bacherini

University of Florence, Italy

Title: The COVID-19 Pandemic from an Ophthalmologist's Perspective


Biography : Daniela Bacherini is Researcher at University of Florence, Eye Clinic. She completed her PhD doctorate in Neuroscience, with particular interest on medical and surgical retinal diseases and retinal imaging. She is Ophthalmology Consultant in medical retina. Her scientific activity and production are dedicated to the study of new retinal imaging techniques. She has active participation in clinical trial.

D. Padmaja

D. Padmaja

Dr NRS Government Ayurvedic Medical College, India

Title: Preventive Role of Ayurvedic Nasya Karma (Errhine) in Covid 19


Biography : D. Padmaja is currently working as a Assistant Professor at Dr NRS Government Ayurvedic Medical College, India. She has received Best Ayurvedic Physician by State Government in 2015 and 2016. Her research interest include cancer treatment.

Why You Should Join?

We believe that our virtual platform offers the scientific community greater opportunity to share their work in a manner that allows them to devote more of their time and funding to engineering and technology itself, while minimizing the expenses and retaining the key benefits of an in-person conference such as learning opportunities, sharing of ideas, and networking.

Great Speakers

Experience powerful education, learning, innovation by internationally recognized speakers.

01

Cost Saving

Engage without the expense and hassle of travel and hotel bookings. Spend your funds on Technology.

02

Easy Access

Accessible from anywhere in the world - Attend any scientific session of your interest.

03

Networking Session

Connects petroleum engineering researchers from all over the globe to network and to share cutting-edge research.

04

Wider Reach

The presentations will remain available one month from the date of the live event for increased reach to the global community.

05

Panel Discussion

Be a part of stimulating discussions by triggering an exchange of viewpoints among experts in E-COVID.

06

Registration

Contact Us

We are ready to lead you into the future of virtual conferences!
Use the below form to drops us an email. We will be in touch with lightning speed.

  • 8105, Suite 112, Rasor Blvd, PLANO, TX 75024
  • +1-469-854-2280/81